Max Weight Loss provides access to compounded medications for qualified patients. Compounded medications are not FDA-approved and may differ in risks, benefits, and side effects from FDA-approved products. Individual results may vary. Novo Nordisk Inc. and Eli Lily and Company are the only U.S. manufacturers of FDA-approved semaglutide (Rybelsus®, Ozempic®, Wegovy®) and tirzepatide (Zepbound®, Mounjaro®), respectively. They do not sell these medications for compounding.

Medical Services are provided via providers at Max Weight Loss. The information provided on this website is for informational purposes and not a substitute for professional medical advice, diagnosis, or treatment. Payment does not guarantee the writing or dispensing of a prescription. If you have questions or concerns about your health, please talk to your doctor. This site is an advertisement for services and not any specific medication.